Art Patent Patent Prosecution Public Use 
43(B)log
NOVEMBER 19, 2021
This designation did not indicate that Valtoco was safe or effective for public use but, instead, operated to qualify Neurelis for various development incentives, like tax credits and potential exclusivity for seven years if the FDA ultimately approved Valtoco.”
Patently-O
JANUARY 21, 2023
Identify any specific sources of prior art not currently available through the Patents End-to-End Search system that you believe examiners should be searching. How, if at all, should the USPTO change RCE practice to achieve the aims of fostering innovation, competition, and access to information through robust and reliable patents?
LexBlog IP
OCTOBER 25, 2022
Patent and Trademark Office (USPTO) recently published a request for comments addressing a variety of topics related to generic drug and biosimilar competition. Senators sent a letter to the USPTO to consider changes to its regulations and practices to address “patent thickets.”
Expert insights. Personalized for you.
56 
Let's personalize your content